Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer.

Bekelman JE, Epstein AJ, Emanuel EJ.

JAMA. 2013 Oct 9;310(14):1501-2. doi: 10.1001/jama.2013.277081. No abstract available.

2.

Radium-223 vs EBRT for multiple painful bone metastases: is less more?

Roach M 3rd.

Oncology (Williston Park). 2014 Apr;28(4):297-8. No abstract available.

3.

Radium-223 vs EBRT for multiple painful bone metastases: the data favor radium-223.

Vogelzang NJ.

Oncology (Williston Park). 2014 Apr;28(4):296, 298. No abstract available.

4.

Radiation for bone metastases.

Bourgeois DJ 3rd, Kraus S, Maaloof BN, Sartor O.

Curr Opin Support Palliat Care. 2011 Sep;5(3):227-32. doi: 10.1097/SPC.0b013e3283499caa. Review.

PMID:
21734581
5.

Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.

Chow E, Danjoux C, Wong R, Szumacher E, Franssen E, Fung K, Finkelstein J, Andersson L, Connolly R.

Radiother Oncol. 2000 Sep;56(3):305-14.

PMID:
10974379
6.

International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?

Fairchild A, Barnes E, Ghosh S, Ben-Josef E, Roos D, Hartsell W, Holt T, Wu J, Janjan N, Chow E.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1501-10. doi: 10.1016/j.ijrobp.2008.12.084. Epub 2009 May 21.

PMID:
19464820
7.

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer.

Robinson TJ, Dinan MA, Li Y, Lee WR, Reed SD.

J Palliat Med. 2015 Nov;18(11):933-9. doi: 10.1089/jpm.2015.0171. Epub 2015 Aug 4.

8.

Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.

Kaasa S, Brenne E, Lund JA, Fayers P, Falkmer U, Holmberg M, Lagerlund M, Bruland O.

Radiother Oncol. 2006 Jun;79(3):278-84. Epub 2006 Jun 21.

PMID:
16793154
9.

[Radiosensitivity of bone metastases from tumors in different primary sites].

Khmelevsky EV, Bychkova NM.

Vopr Onkol. 2015;61(1):77-84. Russian.

PMID:
26016150
10.

Factors affecting the use of single-fraction radiotherapy for the palliation of bone metastases in Australia.

Petrushevski AN, Gabriel GS, Hanna TP, Allen S, Allison RW, Barton MB.

Clin Oncol (R Coll Radiol). 2015 Apr;27(4):205-12. doi: 10.1016/j.clon.2014.11.027. Epub 2014 Dec 17.

PMID:
25533480
11.

Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.

Onukwugha E, Yong C, Hussain A, Seal B, Mullins CD.

BMC Med Res Methodol. 2014 Jan 2;14:1. doi: 10.1186/1471-2288-14-1.

12.

[Optimal doses and timing for tele-irradiation of bone metastases in patients with life expectancy more than 3 months].

KhmelevskiÄ­ EV, Pan'shin GA, Dobrovol'skaia NIu, Bol'shakova SA.

Vopr Onkol. 2012;58(3):380-6. Russian.

PMID:
22888655
13.

Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.

Gandaglia G, Karakiewicz PI, Briganti A, Passoni NM, Schiffmann J, Trudeau V, Graefen M, Montorsi F, Sun M.

Eur Urol. 2015 Aug;68(2):325-34. doi: 10.1016/j.eururo.2014.07.020. Epub 2014 Aug 6.

PMID:
25108577
14.

Did the pattern of practice in the prescription of palliative radiotherapy for the treatment of uncomplicated bone metastases change between 1999 and 2005 at the rapid response radiotherapy program?

Bradley NM, Husted J, Sey MS, Sinclair E, Li KK, Husain AF, Danjoux C, Barnes EA, Tsao MN, Barbera L, Harris K, Chiu H, Doyle M, Chow E.

Clin Oncol (R Coll Radiol). 2008 Jun;20(5):327-36. doi: 10.1016/j.clon.2008.01.002. Epub 2008 Feb 13.

PMID:
18276125
15.

Single fraction radiotherapy for bone metastases: clinically effective, time efficient, cost conscious and still underutilized in the United States?

Hartsell WF, Konski AA, Lo SS, Hayman JA.

Clin Oncol (R Coll Radiol). 2009 Nov;21(9):652-4. doi: 10.1016/j.clon.2009.08.003. Epub 2009 Sep 9. No abstract available.

PMID:
19744843
16.

When should we define the response rates in the treatment of bone metastases by palliative radiotherapy?

Li KK, Hadi S, Kirou-Mauro A, Chow E.

Clin Oncol (R Coll Radiol). 2008 Feb;20(1):83-9. Epub 2007 Nov 5.

PMID:
17981445
17.

Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.

Wu JS, Wong R, Johnston M, Bezjak A, Whelan T; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group.

Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):594-605. Review.

PMID:
12573746
19.

Assessment of national practice for palliative radiation therapy for bone metastases suggests marked underutilization of single-fraction regimens in the United States.

Rutter CE, Yu JB, Wilson LD, Park HS.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):548-55. doi: 10.1016/j.ijrobp.2014.10.045. Epub 2014 Dec 24.

PMID:
25542310
20.

Radiation therapy and radio-nuclides for palliation of bone pain.

Crook J.

Urol Clin North Am. 2006 May;33(2):219-26, vii. Review.

PMID:
16631460

Supplemental Content

Support Center